Abbott Laboratories ABT

NYS: ABT | ISIN: US0028241000 21/10/2026

100,51 USD (-1,89%)

(-1,89%) 21/10/2026

Grafiek Abbott Laboratories

Grafiek Abbott Laboratories

1 dag1d -1,89%
1 week1w -2,39%
1 maand1m -2,40%
3 maanden3m 0,84%
6 maanden6m 8,40%
1 jaar1j -21,19%
5 jaar5j -19,62%

woensdag 21 oktober 2026, 13:00

Kwartaalcijfers (3de kwartaal)

Abbott Laboratories in het nieuws

Toon enkel gratis nieuws

21 oktober 2026 · Nasdaq and Small Caps Lead Three Day Surge as Crude Slides and Blue Chips Hold Firm · Persbericht

21 oktober 2026 · Le Cologuard Plus® d'Abbott obtient le marquage CE pour le dépistage du cancer colorectal en Europe · Persbericht

21 oktober 2026 · Abbott Reports Third-Quarter 2026 Results and Reaffirms Full-Year EPS Guidance · Persbericht

21 oktober 2026 · Abbott announces its intention to separate its global Nutrition business into an independent, publicly traded company · Persbericht

7 oktober 2026 · Abbott introduces Ensure® Max Protein 3-in-1 Muscle Support, bringing the benefits of a supplement stack into one scoop · Persbericht

5 oktober 2026 · Abbott receives FDA approval for new CardioMEMS HF System capabilities that help patients engage in the care of their heart condition · Persbericht

30 september 2026 · Abbott hosts conference call for third-quarter earnings · Persbericht

30 september 2026 · Abbott launches SimpleScreen™ CRC blood test, joining Cologuard Plus® in its colorectal cancer screening portfolio · Persbericht

23 september 2026 · Abbott And Berry Street Partner To Expand Personalized Nutrition Support For Consumers Seeking Better Metabolic Health · Persbericht

17 september 2026 · Abbott declares 411th consecutive quarterly dividend · Persbericht

Profiel Abbott Laboratories

Fabricage van farmaceutische preparaten

Gezondheidstechnologie

Medische Specialiteiten

Website: www.abbott.com

Hoofdzetel: Abbott Park, Illinois Verenigde Staten

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe